MRI-Based Brain Mapping Software Helps Visualize Key Areas during Complex Neurosurgery

The Quicktome FDA-cleared precision brain mapping platform by Omniscient Neurotechnology (o8t, Sydney, Australia) employs artificial intelligence (AI) to analyze millions of data points collected from a standard MRI scan, delivering vital brain insights to neurosurgeons in an accessible and actionable format. The technology makes use of "connectomics," the study of the brain's connections and functional networks. The connectomics-based approach of Quicktome can be tailored and altered to match an individual patient's anatomy and more accurately predict vital regions or networks in their brain, ensuring optimal patient outcomes.

Quicktome is among the first clinical platforms that allow neurosurgeons to create network templates of an individual's cognitive and emotional regulation networks within the brain. Research indicates that damage to these brain networks during surgery can lead to a range of issues, from depression to significant personality changes, seriously impacting a patient’s quality of life. Quicktome's machine learning algorithm produces patient-specific brain maps, which enables physicians to customize surgical approaches based on a patient's individual anatomy.

Related Links:
Omniscient Neurotechnology